Innate Pharma (IPHA)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
189,891,000
EV to revenue ratio (TTM)
42.43
EV to ebitda
-6.94
Financial Performance
Revenue (TTM)
9,808,000
Gross profit (TTM)
-30,169,000
EBITDA
-46,962,000
Profitability
Operating margin (TTM)
-335.70%
Profit margin
0.00%
Return on assets (TTM)
-46.60%
Return on equity (TTM)
-271.40%
Per Share Metrics
Revenue per share (TTM)
0.11
EPS
-0.58
Diluted EPS (TTM)
-0.58
Book value
-0.27
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
19.36
Price to book ratio (TTM)
20.1
Growth
Quarterly earnings growth (YoY)
16.50%
Quarterly revenue growth (YoY)
-74.70%
Analyst Sentiment
Strong buy
0
Buy
3
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.88